检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:高磊[1] 何国平[1] 杨国英[1] 戚传平[2] 马继政[3]
机构地区:[1]江苏大学附属武进医院心内科,江苏省常州市213002 [2]江苏大学附属武进医院检验科,江苏省常州市213002 [3]南京医科大学第一附属医院心血管病研究所,210029
出 处:《实用医学杂志》2009年第3期371-373,共3页The Journal of Practical Medicine
基 金:常州市卫生局重大科研项目(编号:ZD200601)
摘 要:目的:探讨中国华东地区汉族人群血小板反应素-4(thrombospondin-4,TSP-4)基因G29926C(A387P)多态性与早发急性冠脉综合征(ACS)发病的关联性。方法:应用聚合酶链反应-限制性片段长度多态性方法,检测102例早发ACS患者(病例组)和121例年龄及性别相匹配的非冠心病者(对照组)的TSP-4A387P多态性。结果:GC基因型在病例组和对照组的分布差异无统计学意义(5.9%vs7.4%,P=0.64),未检测到CC纯合子。C等位基因频率在病例组和对照组分别为2.9%、3.7%(P=0.65)。Logistic回归分析显示,TSP-4A387P多态性与早发ACS的发生无显著性相关(OR=0.71,95%CI:0.22~2.28,P=0.57)。结论:TSP-4基因387A→P变异在中国华东地区汉族人群中发生频率明显低于西方人群,且与早发ACS的发病无显著相关性。Objective To investigate the association between thrombospondin-4 (TSP-4) gene G29926C (A387P) polymorphism and premature acute coronary syndrome (ACS) in eastern Chinese Han population. Methods The polymorphism of TSP-4 gene A387P were measured by polymerase chain reaction and restriction fragment length polymorphism analysis (PCR-RFLP) in 102 patients with premature ACS (ACS group) and 121 non-coronary heart disease patients (control group), who were matched in age and sex. Results The frequencies of GC genotype were 5.9% in ACS group and 7.4% in control group (P = 0.64), and none of the CC homozygote was detected. The prevalence of C allele was 2.9% in ACS group and 3.7% in control group (P = 0.65). Logistic regression analysis showed there was no significant correlation between TSP-4 gene A387P polymorphism and premature ACS (OR = 0.71, 95% CI: 0.22 - 2.28, P = 0.57). Conclusion The mutation of TSP-4 gene 387A→P is dramatically lower in easter Chinese Han population in than in western populations, and is not significantly associated with the pathogenesis of ACS.
关 键 词:冠状动脉疾病 血小板反应素 基因多态性 聚合酶链反应
分 类 号:R541.4[医药卫生—心血管疾病] R392.11[医药卫生—内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.151